DuckWiseDuckWise Get the app

Archive › BMY

BMY trade ideas: every closed DuckWise idea on Bristol-Myers Squibb Company

DuckWise has published 2 ideas on Bristol-Myers Squibb Company (BMY, Stock) that have closed between December 2020 and February 2022. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.

2closed ideas
2 / 0in profit / at a loss
+15.96%average result
225 daystypical holding period
OpenedClosedSideEntryStopProjectionCloseResultDays
Sep 21, 2021Feb 25, 2022Long60.92—7569.50+15.77%
incl. +1.69% div.
157
Dec 15, 2020Jul 28, 2021Long60.93—8069.30+16.15%
incl. +2.41% div.
225

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.

BMY questions and answers

Has DuckWise published trade ideas on BMY?

Yes. DuckWise has published 2 ideas on Bristol-Myers Squibb Company (BMY) that closed between December 2020 and February 2022: 2 closed in profit and 0 at a loss. The average result was +15.96% from the published entry to the published close, dividends included.

What was the latest closed DuckWise idea on BMY?

A long idea opened on September 21, 2021 with an entry of $60.92 and a price projection of $75.00. It closed on February 25, 2022 at $69.50, a result of +15.77% after 157 days.

How long did DuckWise hold its BMY ideas?

The typical BMY idea was held about 225 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

Is there an open DuckWise idea on BMY right now?

Not at the moment. When DuckWise publishes a new idea on BMY, app subscribers get a push notification; it appears on this page once it closes.

Is this page a stock forecast for BMY or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where BMY will trade. The research is general and impersonal, not a recommendation to buy or sell BMY or any other security.

More trade ideas on the record

Every ticker in the archive · Track record by year

About Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Pays a dividend yield of 3.97% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell BMY or any other security.